We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LOW:NYSELowe's Companies, Inc. Analysis

Data as of 2026-06-04 - not real-time

$207.65

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Lowe’s (LOW) is trading at $207.65, well above its DCF‑derived fair value of $100.82, signaling an **overvalued** pricing level. The stock sits under its 20‑day SMA ($218.98) and 50‑day SMA ($231.33), with a bearish MACD histogram and a 14‑day RSI of 32.9, suggesting short‑term momentum weakness despite being technically oversold. Fundamentally, the company posted a 10.3% revenue growth year‑over‑year, maintains a 33% gross margin and a 7.5% profit margin, and delivered earnings that beat estimates, though its full‑year outlook disappointed investors, prompting a 2.9% post‑earnings decline. The dividend remains attractive at 2.41% with a 40.6% payout ratio, supported by solid free cash flow of $4.8 B. Recent Citi upgrade adds a positive catalyst, but the bearish technical picture and a 27% downside relative to fair value temper enthusiasm.
Overall, while the business fundamentals and dividend profile are sound, the current market price reflects a premium that may be difficult to sustain without clearer guidance or a shift in market sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and RSI indicating weak momentum
  • Support level near $203.40 limiting downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 10% revenue growth and solid margin profile
  • Sustainable dividend yield of 2.41%
  • Citi upgrade and positive earnings surprise

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent cash flow generation and free cash flow
  • Strategic initiatives in contractor services and e‑commerce
  • Long‑term demographic tailwinds for home improvement spending

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin7.51%
P/E Ratio17.6
ROA12.79%
P/B Ratio-12.6
Op. Cash Flow$9.8B
Free Cash Flow$4.8B

Technical Analysis

TrendBearish
RSI32.9
Support$203.40
Resistance$235.60
MA 20$218.98
MA 50$231.33
MA 200$247.79
MACDBearish
VolumeIncreasing
Fear & Greed Index92.75

Valuation

Fair Value$100.82
Target Price$263.73
Upside/Downside27.01%
GradeOvervalued
TypeGrowth
Dividend Yield2.41%

Risk Assessment

Beta0.80
Volatility27.40%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.